118 related articles for article (PubMed ID: 964553)
1. Effect of drug combination of antitumor activity and myelotoxicity.
Fujimoto S; Inouye T; Tsukagoshi S
Gan; 1976 Apr; 67(2):207-14. PubMed ID: 964553
[TBL] [Abstract][Full Text] [Related]
2. Combined effect of cytosine arabinoside and thiopurines.
Valeriote F; Vietti T; Edelstein M
Cancer Treat Rep; 1976 Dec; 60(12):1925-34. PubMed ID: 1026347
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
Fujimoto S; Ogawa M; Hoshino A
Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy of 6-thioguanine with various antitumor agents against murine leukemia L-1210.
Fujimoto S; Inagaki J; Horikoshi N; Hoshino A
Gan; 1977 Oct; 68(5):543-52. PubMed ID: 201534
[TBL] [Abstract][Full Text] [Related]
5. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
Kim K; Blechman WJ; Riddle VG; Pardee AB
Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
[TBL] [Abstract][Full Text] [Related]
6. Combined therapy of L1210 leukemia with Damvar and cytostatics.
Pujman V; Cernochová S
Neoplasma; 1979; 26(5):521-3. PubMed ID: 522924
[TBL] [Abstract][Full Text] [Related]
7. Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemia.
Schmid FA; Hutchison DJ; Otter GM; Stock CC
Cancer Treat Rep; 1976 Jan; 60(1):23-7. PubMed ID: 1000516
[TBL] [Abstract][Full Text] [Related]
8. Scheduling of arabinosylcytosine and 6-thioguanine therapy.
LePage GA; White SC
Cancer Res; 1973 May; 33(5):946-9. PubMed ID: 4703126
[No Abstract] [Full Text] [Related]
9. Therapeutic synergism elicited by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride: synergistic cytocidal activity against L1210 cells in vitro.
Fujimoto S; Ogawa M
Gan; 1980 Oct; 71(5):659-66. PubMed ID: 6939645
[TBL] [Abstract][Full Text] [Related]
10. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine.
Kataoka T; Akahori Y; Sakurai Y
Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
Schwab M; Herrlinger K; Schaeffeler E; Stange EF
Dtsch Med Wochenschr; 2003 Feb; 128(8):378-85. PubMed ID: 12594624
[No Abstract] [Full Text] [Related]
12. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
Avery TL; Roberts D
Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368
[TBL] [Abstract][Full Text] [Related]
13. Acute myelocytic leukemia.
Holland JF; Glidewell O; Ellison RR; Corey RW; Schwartz J; Wallace HJ; Hoagland HC; Wiernik P; Rai K; Bekesi JG; Cuttner J
Arch Intern Med; 1976 Dec; 136(12):1377-81. PubMed ID: 793552
[No Abstract] [Full Text] [Related]
14. Lethal toxicity and myelotoxicity to mice of the combination of 6-thioguanine and 3-[(4-amine-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
Fujimoto S; Ogawa M
Gan; 1980 Oct; 71(5):667-73. PubMed ID: 6939646
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of N6-phenyladenosine, and inhibitor of adenosine utilization, in combination with related purine analogs.
Grindey GB; Divekar AY; Hakala MT
Cancer Res; 1973 Oct; 33(10):2459-63. PubMed ID: 4741936
[No Abstract] [Full Text] [Related]
16. The effect of allopurinol on cyclophosphamide antitumor activity.
Alberts DS; van Daalen Wetters T
Cancer Res; 1976 Aug; 36(8):2790-4. PubMed ID: 1277189
[TBL] [Abstract][Full Text] [Related]
17. [Elimination of suppressor macrophages in tumor-bearing mice by 6-mercaptopurine and its therapeutic contribution].
Kataoka T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):701-5. PubMed ID: 3963841
[TBL] [Abstract][Full Text] [Related]
18. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
Panasci LC; Green D; Schein PS
J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the antitumor effect of 6-mercaptopurine by vitamin A.
Akiyama S; Masuda A; Tabuki T; Kuwano M; Komiyama S
Gan; 1981 Oct; 72(5):742-6. PubMed ID: 7199007
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide. I. Effects of survival and colony-forming cells in BDF1 L-1210-bearing mice.
Pazdernik TL; Uyeki EM
J Pharmacol Exp Ther; 1978 Oct; 207(1):255-61. PubMed ID: 702348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
